New research shows combining Mediterranean polyphenols with ketogenic fats improves mitochondrial function in HD models, while time-restricted eating enhances therapeutic ketosis and autophagy. Phase ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A new clinical trial explores time-restricted eating for Huntington’s disease, building on recent research showing benefits for mitochondrial function and autophagy. A groundbreaking clinical trial ...
A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
Johns Hopkins Hospital’s pilot study reveals ADAM sensors with AI biofeedback improve swallow frequency by 45%, reducing aspiration pneumonia risk by 32%, now under FDA fast-track review. Breakt...
A 12-week clinical trial explores time-restricted eating’s effects on cognitive function and mitochondrial health in Huntington’s disease patients. New research investigates whether time-restr...
New clinical trial explores time-restricted eating’s potential benefits for Huntington’s disease patients, focusing on metabolic health and symptom management. A groundbreaking clinical tr...
A recent PLoS One study reveals that a 12-week time-restricted eating protocol improves mitochondrial function and reduces polyQ aggregation in Huntington’s disease patients. Groundbreaking rese...
Recent studies suggest time-restricted eating may offer neuroprotective benefits for Huntington’s disease by improving mitochondrial function and reducing oxidative stress. Emerging research indicat...
